Scientists have created synthetic yeast that converts human urine into a valuable bone implant material, while also reducing ...

Scientists have identified a protein that blocks the activity of bone-forming cells (osteoblasts) by stopping them from maturing during the journey to sites of bone formation, a new study has found.

our work suggests that increased mtROS or decreased Atg7-dependent autophagy in osteoblastic cells, as well as reduced osteocyte dendrite number – common features of aged bone – do not ...

For some, Osteoboost might initially evoke TV informercials for gadgets that promise to shock people's abdominal muscles into ...

Type-H endothelial cell protein Clec14a orchestrates osteoblast activity during trabecular bone formation and patterning. Communications Biology , 2024; 7 (1) DOI: 10.1038/s42003-024-06971-3 Cite ...

Treatment with R992 also reduced bone loss and the number of bone metastases in mouse models with myeloma, lung cancer and breast cancer cell lines. The agent R992 is not approved as a drug.

titled "Mitochondrial oxidative stress or decreased autophagy in osteoblast lineage cells is not sufficient to mimic the deleterious effects of aging on bone mechanoresponsiveness." Researchers ...

the DPSC clusters had higher differentiation potential and more readily and easily converted to osteoblasts, cells that form new or repair existing bone. “This new information on the specific ...

Two kinds of bone cells work together to keep bones healthy: osteoclasts and osteoblasts. Osteoclasts are cells in the body that play a role in breaking down old bone tissue. Osteoblasts then play ...

Osteoclasts are bone cells that dissolve old tissue, and osteoblasts are cells that replace the old tissue with new bone. Bone cancer may be primary, which means it originates in the bone ...